{
  "cik": 1652935,
  "cik_padded": "0001652935",
  "entityName": "ACTUATE THERAPEUTICS, INC.",
  "fiscal_years": [
    {
      "accn": "0001683168-26-002257",
      "filed": "2026-03-26",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 13159423.0,
        "eps_diluted": -1.06,
        "net_income": -22227852.0,
        "operating_cash_flow": -19206253.0,
        "operating_income": -22495312.0,
        "stockholders_equity": 7924003.0,
        "total_assets": 14035910.0,
        "total_liabilities": 6111907.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.7713155838027825,
        "roa_avg2y": -1.9035292684988385,
        "roa_period_end": -1.5836416733934597,
        "roe_avg2y": -5.537451098871738,
        "roe_period_end": -2.805129175241352
      }
    },
    {
      "accn": "0001683168-26-002257",
      "filed": "2026-03-26",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 8641622.0,
        "eps_diluted": -3.26,
        "net_income": -27285328.0,
        "operating_cash_flow": -21842648.0,
        "operating_income": -25160734.0,
        "stockholders_equity": 104186.0,
        "total_assets": 9318448.0,
        "total_liabilities": 9214262.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "leverage": 88.44050064308064,
        "roa_avg2y": -4.431589569412541,
        "roe_avg2y": 0.5483257641272797
      }
    },
    {
      "accn": "0001683168-26-002257",
      "filed": "2026-03-26",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "eps_diluted": -17.24,
        "net_income": -24744620.0,
        "operating_cash_flow": -21625167.0,
        "operating_income": -24973829.0,
        "stockholders_equity": -99626513.0,
        "total_assets": 2995566.0,
        "total_liabilities": 8443675.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roe_avg2y": 0.28290567511840103
      }
    },
    {
      "accn": "0001683168-25-001581",
      "filed": "2025-03-13",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -75305432.0
      },
      "period_end": "2022-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001683168-26-002257",
    "filed": "2026-03-26",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001652935.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001652935.json"
  },
  "ticker": "ACTU"
}